ArticleHealth research policy and systems2022
How can health technology assessment support our response to public health emergencies?
Article in Health research policy and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.PharmacoEconomics · 2024Pooled it
- Global partnerships for local impact: Strengthening HTA capacity in Asia and Africa through collaborative experiences.Health research policy and systems · 2026Article
- Ethical Considerations in Health Technology Assessment for Precision Medicine: A Delphi Study in a Greek Setting.Journal of personalized medicine · 2026Article
- Health technology assessment system in Switzerland: Current state, gaps, and prospects for improvement.PLOS global public health · 2026Article
- Assessment of emergency management capabilities for public health emergencies in China.Frontiers in public health · 2026Article
- Understanding the layout of emergency scientific research during COVID-19 prevention and control: a comparative analysis of project solicitation and project approval.BMC public health · 2025Article
- Health research versus the virus: strengthening systems, saving lives.Health research policy and systems · 2025Article
- Gaps and opportunities for data systems and economics to support priority setting for climate-sensitive infectious diseases in sub-Saharan Africa: A rapid scoping review.PLOS global public health · 2025Article
- Impact of COVID-19 pandemic on HTAsiaLink network members.International journal of technology assessment in health care · 2024Article
- Economic Rationality in Decision-Making Regarding Newborn Screening: A Case Study in Quebec.International journal of neonatal screening · 2024Article
- A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.International journal of technology assessment in health care · 2024Article
- Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design.Cost effectiveness and resource allocation : C/E · 2024Article
- Moving from intervention management to disease management: a qualitative study exploring a systems approach to health technology assessment in Canada.International journal of technology assessment in health care · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Public health emergencies (PHEs), such as the COVID-19 crisis, are threats to global health and public order. We recommend that countries bolster their PHE responses by investing in health technology assessment (HTA), defined as a systematic process of gathering pertinent information on and evaluating health technologies from a medical, economic, social and ethical standpoint. We present examples of how HTA organizations in low- and middle-income countries have adapted to supporting PHE-related decisions during COVID-19 and describe the ways HTA can help the response to a PHE. In turn, we advocate for HTA capacity to be further developed globally and for increased institutional acceptance of these methods as a building block for preparedness and response to future PHEs. Finally, the long-term potential of HTA in strengthening health systems and embedding confidence and transparency into scientific policy should be recognized.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.